HK1068878A1 - Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivatives - Google Patents
Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivativesInfo
- Publication number
- HK1068878A1 HK1068878A1 HK05101237A HK05101237A HK1068878A1 HK 1068878 A1 HK1068878 A1 HK 1068878A1 HK 05101237 A HK05101237 A HK 05101237A HK 05101237 A HK05101237 A HK 05101237A HK 1068878 A1 HK1068878 A1 HK 1068878A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diseases
- disorders
- diazabicyclo
- novel
- nervous system
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200100344 | 2001-03-02 | ||
PCT/DK2002/000133 WO2002070522A1 (fr) | 2001-03-02 | 2002-02-28 | Nouveaux derives de 2,5-diazabicyclo[2.2.1]heptane |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1068878A1 true HK1068878A1 (en) | 2005-05-06 |
Family
ID=8160337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05101237A HK1068878A1 (en) | 2001-03-02 | 2005-02-16 | Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivatives |
Country Status (13)
Country | Link |
---|---|
US (1) | US7329754B2 (fr) |
EP (1) | EP1368348B1 (fr) |
JP (1) | JP4294958B2 (fr) |
CN (1) | CN1331864C (fr) |
AT (1) | ATE287404T1 (fr) |
AU (1) | AU2002233181B2 (fr) |
CA (1) | CA2438815A1 (fr) |
DE (1) | DE60202667T2 (fr) |
DK (1) | DK1368348T3 (fr) |
HK (1) | HK1068878A1 (fr) |
MX (1) | MXPA03007895A (fr) |
NZ (1) | NZ527006A (fr) |
WO (1) | WO2002070522A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2468015A1 (fr) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | Composes de 2-aminoquinoline |
AU2009214190A1 (en) * | 2008-02-15 | 2009-08-20 | F. Hoffmann-La Roche Ag | 3-alkyl-piperazine derivatives and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166416B (fr) * | 1985-09-18 | 1990-05-05 | Pfizer | |
US5196548A (en) | 1989-05-11 | 1993-03-23 | Pfizer Inc. | Preparation of diazabicyclic Intermediates |
JPH06228138A (ja) | 1993-02-03 | 1994-08-16 | Fujisawa Pharmaceut Co Ltd | ピリドシンノリン化合物またはその塩及びこれを含有する抗菌剤 |
US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
US5561127A (en) | 1994-12-19 | 1996-10-01 | Allelix Biopharmaceuticals, Inc. | Muscarinic receptor ligands |
FR2786769B1 (fr) * | 1998-12-04 | 2002-10-25 | Synthelabo | Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique |
BR0007664A (pt) * | 1999-01-29 | 2002-05-07 | Abbott Lab | Derivados diazabicìclicos como ligantes receptores de acetilcolina nicotìnicos |
US6852721B2 (en) | 2000-05-25 | 2005-02-08 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
CA2354606C (fr) * | 2000-08-03 | 2005-12-06 | Pfizer Products Inc. | Derives d'azabicycloalkane et utilisations therapeutiques connexes |
-
2002
- 2002-02-28 WO PCT/DK2002/000133 patent/WO2002070522A1/fr active IP Right Grant
- 2002-02-28 NZ NZ527006A patent/NZ527006A/en unknown
- 2002-02-28 AU AU2002233181A patent/AU2002233181B2/en not_active Ceased
- 2002-02-28 DE DE60202667T patent/DE60202667T2/de not_active Expired - Lifetime
- 2002-02-28 EP EP02700189A patent/EP1368348B1/fr not_active Expired - Lifetime
- 2002-02-28 AT AT02700189T patent/ATE287404T1/de not_active IP Right Cessation
- 2002-02-28 CN CNB028050770A patent/CN1331864C/zh not_active Expired - Fee Related
- 2002-02-28 MX MXPA03007895A patent/MXPA03007895A/es active IP Right Grant
- 2002-02-28 DK DK02700189T patent/DK1368348T3/da active
- 2002-02-28 CA CA002438815A patent/CA2438815A1/fr not_active Abandoned
- 2002-02-28 US US10/250,765 patent/US7329754B2/en not_active Expired - Fee Related
- 2002-02-28 JP JP2002569842A patent/JP4294958B2/ja not_active Expired - Fee Related
-
2005
- 2005-02-16 HK HK05101237A patent/HK1068878A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ527006A (en) | 2005-02-25 |
CA2438815A1 (fr) | 2002-09-12 |
CN1331864C (zh) | 2007-08-15 |
ATE287404T1 (de) | 2005-02-15 |
DK1368348T3 (da) | 2005-05-23 |
EP1368348B1 (fr) | 2005-01-19 |
DE60202667T2 (de) | 2005-06-16 |
WO2002070522A1 (fr) | 2002-09-12 |
JP2004529901A (ja) | 2004-09-30 |
US7329754B2 (en) | 2008-02-12 |
AU2002233181B2 (en) | 2007-06-07 |
CN1535273A (zh) | 2004-10-06 |
JP4294958B2 (ja) | 2009-07-15 |
DE60202667D1 (de) | 2005-02-24 |
MXPA03007895A (es) | 2003-12-04 |
EP1368348A1 (fr) | 2003-12-10 |
US20040181069A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166254A0 (en) | Novel quinuclidine derivatives and their use | |
HK1068628A1 (en) | Nicotinic acetyl-choline receptors inhibitor compounds, their preparation and use | |
PL375025A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
AU2002220517A1 (en) | 3-substituted quinuclidines and their use as nicotinic agonists | |
AU6583101A (en) | Aryl and heteroaryl diazabicycloalkanes, their preparation and use | |
MXPA04010966A (es) | Derivados novedosos de biarilo diazabiciclico. | |
AU2003280309A1 (en) | 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof | |
IL186360A0 (en) | Novel oxadiazole derivatives and their medical use | |
ATE289310T1 (de) | Heteroaryl-diazabicycloalkanderivaten als cns- modulatoren | |
AU1996301A (en) | Novel heteroaryl-diazabicycloalkanes | |
HK1079528A1 (en) | Azacyclic ethynyl derivatives | |
MXPA05006861A (es) | Derivados arildiazabiciclicos novedosos. | |
DE60307102D1 (de) | 3-substituierte chinuklidine und deren verwendung | |
HK1068878A1 (en) | Novel 2, 5-diazabicyclo Ä2.2.1Üheptane derivatives | |
MX2007003331A (es) | Nuevos derivados de arilo diazabiciclico. | |
MXPA05003344A (es) | Derivados novedosos de 1,4-diazabicicloalcano, su preparacion y uso. | |
MX2007004245A (es) | Nuevos derivados de arilo azabiciclicos y su uso medico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110228 |